Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Reuters reported on January 20 that Britain's GSK and Japan's Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV-focused joint venture, ViiV Healthcare. The transaction values Pfizer's exit at about $1.9 billion and sharply increases Shionogi's stake in the business. Under the deal, Shionogi will pay $2.13 billion for newly issued shares, lifting its ownership in ViiV Healthcare to 21.7% from 10%. GSK will continue to control the company, keeping its 78.3% majority stake. Pfizer will receive $1.88 billion for its 11.7% holding. GSK, meanwhile, will receive a $250 million special dividend as ViiV cancels Pfizer's shares. GSK originally formed ViiV Healthcare with Pfizer in 2009, with Shionogi joining the venture in 2012. The companies said the deal is subject to regulatory approvals and is expected to close in the first quarter of 2026. Pfizer's exit comes as the company braces for a more difficult stretch. In December, it warned that the years ahead could be bumpy, starti
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer: A High-Yield Pharma At A Turning Point [Seeking Alpha]Seeking Alpha
- Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies [Yahoo! Finance]Yahoo! Finance
- Pfizer (NYSE:PFE) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.MarketBeat
- Pfizer: Expect Another Double Beating For Q1 (Earnings Preview) [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 1/16/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- PFE's page on the SEC website